Laparoscopic Staging in Patients with Newly Diagnosed Pancreatic Cancer View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2016

AUTHORS

Timothy Gilbert , Ryan Baron , Paula Ghaneh , Christopher Halloran

ABSTRACT

Prompt accurate staging Laparoscopic stagingSee Staging laparoscopy (SL)is paramount in managing patients with newly diagnosed pancreatic cancer. Initially, diagnosis and staging are undertaken using contrast-enhanced multidetector computerized tomography (CE-MDCT) or magnetic resonance imaging (MRI), supplemented with endoscopic ultrasound in selected cases. Staging laparoscopy (SL) with or without laparoscopic ultrasound (L-LUS) has been found to detect occult disease in 13–28% of patients with pancreatic cancer who are considered potentially resectable on imaging; however, between 1% and 30% of patients thought to be resectable on SL/L-LUS have subsequently been found to have unresectable disease. The clinical utility of SL/L-LUS can be enhanced by adopting a selective approach, only undertaking SL/L-LUS when one or more criteria are present, including (1) presumed pancreatic primary >3 cm diameter, (2) lesions in the body and tail of the pancreas, (3) CA 19–9>150 kU/L (>300 when total bilirubin >35 micromol/L), and (4) platelet/lymphocyte ratio >150. The judicious use of SL/L-LUS and cross-sectional imaging are complementary; however, the advent of PET-CT may lead to improvements in the detection of small previously radiologically occult metastases and may reduce the future role of SL/L-LUS. More... »

PAGES

1-17

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4939-6631-8_80-1

DOI

http://dx.doi.org/10.1007/978-1-4939-6631-8_80-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1084721051


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gilbert", 
        "givenName": "Timothy", 
        "id": "sg:person.014614756205.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014614756205.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baron", 
        "givenName": "Ryan", 
        "id": "sg:person.013334614633.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013334614633.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ghaneh", 
        "givenName": "Paula", 
        "id": "sg:person.07372440237.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK", 
          "id": "http://www.grid.ac/institutes/grid.10025.36", 
          "name": [
            "Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Halloran", 
        "givenName": "Christopher", 
        "id": "sg:person.0757621000.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757621000.67"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2016", 
    "datePublishedReg": "2016-01-01", 
    "description": "Prompt accurate staging Laparoscopic stagingSee Staging laparoscopy (SL)is paramount in managing patients with newly diagnosed pancreatic cancer. Initially, diagnosis and staging are undertaken using contrast-enhanced multidetector computerized tomography (CE-MDCT) or magnetic resonance imaging (MRI), supplemented with endoscopic ultrasound in selected cases. Staging laparoscopy (SL) with or without laparoscopic ultrasound (L-LUS) has been found to detect occult disease in 13\u201328% of patients with pancreatic cancer who are considered potentially resectable on imaging; however, between 1% and 30% of patients thought to be resectable on SL/L-LUS have subsequently been found to have unresectable disease. The clinical utility of SL/L-LUS can be enhanced by adopting a selective approach, only undertaking SL/L-LUS when one or more criteria are present, including (1) presumed pancreatic primary >3\u00a0cm diameter, (2) lesions in the body and tail of the pancreas, (3) CA 19\u20139>150\u00a0kU/L (>300 when total bilirubin >35\u00a0micromol/L), and (4) platelet/lymphocyte ratio >150. The judicious use of SL/L-LUS and cross-sectional imaging are complementary; however, the advent of PET-CT may lead to improvements in the detection of small previously radiologically occult metastases and may reduce the future role of SL/L-LUS.", 
    "editor": [
      {
        "familyName": "Neoptolemos", 
        "givenName": "John P.", 
        "type": "Person"
      }, 
      {
        "familyName": "Urrutia", 
        "givenName": "Raul", 
        "type": "Person"
      }, 
      {
        "familyName": "Abbruzzese", 
        "givenName": "James", 
        "type": "Person"
      }, 
      {
        "familyName": "B\u00fcchler", 
        "givenName": "Markus W.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4939-6631-8_80-1", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4939-6631-8", 
        "978-1-4939-6631-8"
      ], 
      "name": "Pancreatic Cancer", 
      "type": "Book"
    }, 
    "keywords": [
      "pancreatic cancer", 
      "magnetic resonance imaging", 
      "platelet/lymphocyte ratio", 
      "multidetector computerized tomography", 
      "kU/L", 
      "cross-sectional imaging", 
      "staging laparoscopy", 
      "unresectable disease", 
      "occult metastases", 
      "laparoscopic staging", 
      "occult disease", 
      "lymphocyte ratio", 
      "CA 19", 
      "pancreatic primary", 
      "endoscopic ultrasound", 
      "PET-CT", 
      "laparoscopic ultrasound", 
      "clinical utility", 
      "computerized tomography", 
      "patients", 
      "resonance imaging", 
      "cancer", 
      "judicious use", 
      "laparoscopy", 
      "staging", 
      "disease", 
      "selective approach", 
      "ultrasound", 
      "more criteria", 
      "imaging", 
      "metastasis", 
      "future role", 
      "lesions", 
      "pancreas", 
      "diagnosis", 
      "tomography", 
      "Newly", 
      "primary", 
      "criteria", 
      "cases", 
      "role", 
      "utility", 
      "improvement", 
      "body", 
      "use", 
      "advent", 
      "detection", 
      "paramount", 
      "ratio", 
      "diameter", 
      "tail", 
      "approach"
    ], 
    "name": "Laparoscopic Staging in Patients with Newly Diagnosed Pancreatic Cancer", 
    "pagination": "1-17", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1084721051"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4939-6631-8_80-1"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4939-6631-8_80-1", 
      "https://app.dimensions.ai/details/publication/pub.1084721051"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-10-01T06:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/chapter/chapter_122.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4939-6631-8_80-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-6631-8_80-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-6631-8_80-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-6631-8_80-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-6631-8_80-1'


 

This table displays all metadata directly associated to this object as RDF triples.

146 TRIPLES      22 PREDICATES      77 URIs      70 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4939-6631-8_80-1 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Ndac656c286f24cf0bade1b59762af7b1
4 schema:datePublished 2016
5 schema:datePublishedReg 2016-01-01
6 schema:description Prompt accurate staging Laparoscopic stagingSee Staging laparoscopy (SL)is paramount in managing patients with newly diagnosed pancreatic cancer. Initially, diagnosis and staging are undertaken using contrast-enhanced multidetector computerized tomography (CE-MDCT) or magnetic resonance imaging (MRI), supplemented with endoscopic ultrasound in selected cases. Staging laparoscopy (SL) with or without laparoscopic ultrasound (L-LUS) has been found to detect occult disease in 13–28% of patients with pancreatic cancer who are considered potentially resectable on imaging; however, between 1% and 30% of patients thought to be resectable on SL/L-LUS have subsequently been found to have unresectable disease. The clinical utility of SL/L-LUS can be enhanced by adopting a selective approach, only undertaking SL/L-LUS when one or more criteria are present, including (1) presumed pancreatic primary >3 cm diameter, (2) lesions in the body and tail of the pancreas, (3) CA 19–9>150 kU/L (>300 when total bilirubin >35 micromol/L), and (4) platelet/lymphocyte ratio >150. The judicious use of SL/L-LUS and cross-sectional imaging are complementary; however, the advent of PET-CT may lead to improvements in the detection of small previously radiologically occult metastases and may reduce the future role of SL/L-LUS.
7 schema:editor Nd322e07ed84d4b2ebd601bd7304c789b
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf Ne3d836b360bb4b39af79278d598c26dc
11 schema:keywords CA 19
12 Newly
13 PET-CT
14 advent
15 approach
16 body
17 cancer
18 cases
19 clinical utility
20 computerized tomography
21 criteria
22 cross-sectional imaging
23 detection
24 diagnosis
25 diameter
26 disease
27 endoscopic ultrasound
28 future role
29 imaging
30 improvement
31 judicious use
32 kU/L
33 laparoscopic staging
34 laparoscopic ultrasound
35 laparoscopy
36 lesions
37 lymphocyte ratio
38 magnetic resonance imaging
39 metastasis
40 more criteria
41 multidetector computerized tomography
42 occult disease
43 occult metastases
44 pancreas
45 pancreatic cancer
46 pancreatic primary
47 paramount
48 patients
49 platelet/lymphocyte ratio
50 primary
51 ratio
52 resonance imaging
53 role
54 selective approach
55 staging
56 staging laparoscopy
57 tail
58 tomography
59 ultrasound
60 unresectable disease
61 use
62 utility
63 schema:name Laparoscopic Staging in Patients with Newly Diagnosed Pancreatic Cancer
64 schema:pagination 1-17
65 schema:productId N34a9b6c038444788a48ce8170f13183a
66 N5ea6ae6d4ded41bc9c3209ac58db73fe
67 schema:publisher Ndeea8ceac8be4ac592123c58360992da
68 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084721051
69 https://doi.org/10.1007/978-1-4939-6631-8_80-1
70 schema:sdDatePublished 2022-10-01T06:52
71 schema:sdLicense https://scigraph.springernature.com/explorer/license/
72 schema:sdPublisher N426c5cdfa97e45e6b1c2d583271babeb
73 schema:url https://doi.org/10.1007/978-1-4939-6631-8_80-1
74 sgo:license sg:explorer/license/
75 sgo:sdDataset chapters
76 rdf:type schema:Chapter
77 N193cf1f321124f2b907db382dcff26bb rdf:first Ne4c3a41427774763902b209b80fea5eb
78 rdf:rest Neb442dc591954b66bdc38d2f1068b9ad
79 N33302fd4d33f4c00aba48d67faafa41b rdf:first sg:person.0757621000.67
80 rdf:rest rdf:nil
81 N34a9b6c038444788a48ce8170f13183a schema:name dimensions_id
82 schema:value pub.1084721051
83 rdf:type schema:PropertyValue
84 N426c5cdfa97e45e6b1c2d583271babeb schema:name Springer Nature - SN SciGraph project
85 rdf:type schema:Organization
86 N5ea6ae6d4ded41bc9c3209ac58db73fe schema:name doi
87 schema:value 10.1007/978-1-4939-6631-8_80-1
88 rdf:type schema:PropertyValue
89 N65503ed69ae2463ba675c57005114f0c rdf:first sg:person.07372440237.86
90 rdf:rest N33302fd4d33f4c00aba48d67faafa41b
91 Nb1101605bc52414b967160c8ece3705b schema:familyName Neoptolemos
92 schema:givenName John P.
93 rdf:type schema:Person
94 Nd322e07ed84d4b2ebd601bd7304c789b rdf:first Nb1101605bc52414b967160c8ece3705b
95 rdf:rest N193cf1f321124f2b907db382dcff26bb
96 Nd36a0967d8794c838055f47b5497fa8e schema:familyName Büchler
97 schema:givenName Markus W.
98 rdf:type schema:Person
99 Ndac656c286f24cf0bade1b59762af7b1 rdf:first sg:person.014614756205.88
100 rdf:rest Nde10083f15db4525a043a8e39d2c2b64
101 Nde10083f15db4525a043a8e39d2c2b64 rdf:first sg:person.013334614633.40
102 rdf:rest N65503ed69ae2463ba675c57005114f0c
103 Ndeea8ceac8be4ac592123c58360992da schema:name Springer Nature
104 rdf:type schema:Organisation
105 Ne3d836b360bb4b39af79278d598c26dc schema:isbn 978-1-4939-6631-8
106 schema:name Pancreatic Cancer
107 rdf:type schema:Book
108 Ne4c3a41427774763902b209b80fea5eb schema:familyName Urrutia
109 schema:givenName Raul
110 rdf:type schema:Person
111 Ne93b85685a03404fa85e3bfbf036e602 schema:familyName Abbruzzese
112 schema:givenName James
113 rdf:type schema:Person
114 Neb442dc591954b66bdc38d2f1068b9ad rdf:first Ne93b85685a03404fa85e3bfbf036e602
115 rdf:rest Nf6a604cba5af4593968bddd12273c410
116 Nf6a604cba5af4593968bddd12273c410 rdf:first Nd36a0967d8794c838055f47b5497fa8e
117 rdf:rest rdf:nil
118 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
119 schema:name Medical and Health Sciences
120 rdf:type schema:DefinedTerm
121 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
122 schema:name Oncology and Carcinogenesis
123 rdf:type schema:DefinedTerm
124 sg:person.013334614633.40 schema:affiliation grid-institutes:grid.10025.36
125 schema:familyName Baron
126 schema:givenName Ryan
127 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013334614633.40
128 rdf:type schema:Person
129 sg:person.014614756205.88 schema:affiliation grid-institutes:grid.10025.36
130 schema:familyName Gilbert
131 schema:givenName Timothy
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014614756205.88
133 rdf:type schema:Person
134 sg:person.07372440237.86 schema:affiliation grid-institutes:grid.10025.36
135 schema:familyName Ghaneh
136 schema:givenName Paula
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86
138 rdf:type schema:Person
139 sg:person.0757621000.67 schema:affiliation grid-institutes:grid.10025.36
140 schema:familyName Halloran
141 schema:givenName Christopher
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757621000.67
143 rdf:type schema:Person
144 grid-institutes:grid.10025.36 schema:alternateName Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK
145 schema:name Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, L69 3GA, Liverpool, UK
146 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...